Skip to main content
. 2020 Sep 11;13:9043–9057. doi: 10.2147/OTT.S262084

Figure 5.

Figure 5

DCA of nomogram and TNM stage for prediction of PFS and OS of ES-SCLC patients. The dash line represents the net benefit of nomogram and TNM stage. (A) DCA of nomogram and TNM stage for prediction of 6-month PFS of ES-SCLC patients; (B) DCA of nomogram and TNM stage for prediction of 12-month OS of ES-SCLC patients.

Abbreviations: PFS, progression-free survival; OS, overall survival; ES-SCLC, extensive-stage small-cell lung cancer.